Zinzani PL, Chen R, Armand P, Johnson NA, et al. Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis. Leuk Lymphoma 2020 Jan 6:1-5. doi: 10.1080/10428194.2019.1702178.
PMID: 31905294